Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediTrust Health operates an innovative healthcare payment and medical welfare management platform in China. Its core product, Care2Pay, connects pharmaceutical companies, pharmacies, insurers, and patients to improve drug accessibility and affordability—especially for chronic disease and specialty drugs. The company offers online consultations, medication search tools, customized insurance products, patient education resources, and an e-commerce marketplace for health-related goods. It has raised over $466 million in funding through Series C rounds with a reported valuation of $1.6 billion as of early 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediTrust Health.